Facebook
Messenger
Twitter
LinkedIn
Email
Printlenzilumab
Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor (CAR)-T cell therapy in treating cancer. They presented[...]
Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor (CAR)-T cell therapy in treating cancer. They presented[...]